2016 NCATS/NIH R21 Grant

David Sullivan, MD, professor at Johns Hopkins Bloomberg School of Public Health has been awarded a 2-year R21 grant to investigate the preclinical activities of cethromycin in a malaria mouse model and to measure drug levels directly at the site of action in the liver. This R21 funding mechanism supports rigorous, pre-clinical studies that establish […]